| Literature DB >> 33455996 |
Chao Fang1, Jia Lu1, Shaotao Zhang1, Jifei Wang1, Yidan Wang1, Lulu Li1, Yini Wang1, Senqing Jiang1, Yanwei Yin1, Junchen Guo1, Fangmeng Lei1, Huai Yu1, Guo Wei1, Yuan Yao1, Tao Chen1, Xuefeng Ren1, Lei Xing1, Yingfeng Tu1, Jingbo Hou1, Jiannan Dai1, Bo Yu1.
Abstract
AIMS: Recent studies suggested plaque erosion with noncritical stenosis could be treated distinctly from that with critical stenosis, but their morphological features remained largely unknown. The present study aimed to investigate morphological features of eroded plaques with different lumen stenosis using optical coherence tomography (OCT).Entities:
Keywords: Bifurcation; Coronary stenosis; Myocardial infarction; Optical coherence tomography; Plaque erosion
Mesh:
Year: 2021 PMID: 33455996 PMCID: PMC8737071 DOI: 10.5551/jat.60301
Source DB: PubMed Journal: J Atheroscler Thromb ISSN: 1340-3478 Impact factor: 4.928
Fig.1. Study flowchartAS, area stenosis; OCT, optical coherence tomography; STEMI, ST-segment elevated myocardial infarction.
Clinical characteristics and coronary angiographic findings of STEMI patients with OCT-erosion
| Variables | Area stenosis |
| |||||
|---|---|---|---|---|---|---|---|
|
Group A
<50% (
|
Group B
50-75% (
|
Group C
≥ 75% (
|
A vs. B vs. C | A vs. B | B vs. C | A vs. C | |
| Clinical characteristics | |||||||
| Age, years | 51.3±12.8 | 53.6±10.0 | 56.3±11.1 | 0.008 | 0.195 | 0.031 | 0.005 |
| Male | 42 (84.0) | 115 (78.8) | 119 (78.3) | 0.673 | NA | NA | NA |
| Smoking status | 0.226 | NA | NA | NA | |||
| Never | 14 (28.0) | 38 (26.0) | 49 (32.2) | ||||
| Former | 6 (12.0) | 7 (4.8) | 14 (9.2) | ||||
| Current | 30 (60.0) | 101 (69.2) | 89 (58.6) | ||||
| Diabetes mellitus | 5 (10.0) | 21 (14.4) | 26 (17.1) | 0.459 | NA | NA | NA |
| Hypertension | 11 (22.0) | 49 (33.6) | 64 (42.1) | 0.029 | 0.126 | 0.129 | 0.011 |
| Dyslipidemia | 21 (42.0) | 80 (54.8) | 65 (42.8) | 0.079 | NA | NA | NA |
| CKD | 4 (8.0) | 7 (4.8) | 9 (5.9) | 0.697 | NA | NA | NA |
| Laboratory test | |||||||
| TC, mg/dL | 186.3±63.7 | 177.8±37.4 | 175.6±38.7 | 0.306 | NA | NA | NA |
| TG, mg/dL | 136.7±74.7 | 142.1±78.6 | 131.8±78.9 | 0.526 | NA | NA | NA |
| LDL-C, mg/dL | 109.5±33.9 | 117.4±45.7 | 109.6±34.7 | 0.194 | NA | NA | NA |
| HDL-C, mg/dL | 52.0±9.7 | 49.7±11.7 | 50.3±11.4 | 0.469 | NA | NA | NA |
| cTnI, µg/L | 2.9 (0.3, 55.1) | 1.5 (0.2, 8.8) | 1.5 (0.3, 10.0) | 0.173 | NA | NA | NA |
| CK-MB, U/L | 19.5 (2.9, 149.5) | 13.2 (1.9, 64.5) | 14.6 (1.9, 85.0) | 0.252 | NA | NA | NA |
| hs-CRP, mg/L | 6.8±5.3 | 6.9±5.1 | 6.0±4.9 | 0.274 | NA | NA | NA |
| pro-BNP, pg/mL | 441.0 (77.5, 1106.5) | 305.0 (79.5, 1376.0) | 262.0 (60.3, 1242.3) | 0.799 | NA | NA | NA |
| STEMI onset to OCT imaging time, min | 326.0 (210.0, 522.0) | 285.5 (187.8, 456.0) | 316.0 (205.0, 517.0) | 0.454 | NA | NA | NA |
| Coronary angiographic findings | |||||||
| Culprit vessel | 0.039 | 0.529 | 0.063 | 0.076 | |||
| LAD | 36 (72.0) | 99 (67.8) | 82 (53.9) | ||||
| LCX | 2 (4.0) | 13 (8.9) | 13 (8.6) | ||||
| RCA | 12 (24.0) | 34 (23.3) | 57 (37.5) | ||||
| Segment | 0.201 | NA | NA | NA | |||
| Proximal | 20 (40.0) | 76 (52.1) | 63 (41.4) | ||||
| Mid | 18 (36.0) | 51 (34.9) | 63 (41.4) | ||||
| Distal | 12 (24.0) | 19 (13.0) | 26 (17.1) | ||||
| Lesion length, mm | 18.8±8.7 | 18.0±8.8 | 18.2±9.0 | 0.850 | NA | NA | NA |
| RLD, mm | 3.2±0.6 | 3.1±0.6 | 3.1±0.5 | 0.231 | NA | NA | NA |
| MLD, mm | 1.5±0.7 | 1.2±0.5 | 1.0±0.4 | <0.001 | <0.001 | 0.002 | <0.001 |
| DS, % | 53.7±18.3 | 62.0±13.7 | 67.8±10.9 | <0.001 | 0.001 | <0.001 | 0.001 |
| Initial TIMI flow 0-1 | 31 (62.0) | 98 (67.1) | 97 (63.8) | 0.748 | NA | NA | NA |
| Multivessel disease | 12 (24.0) | 44 (30.1) | 60 (39.5) | 0.074 | NA | NA | NA |
| Thrombolysis | 3 (6.0) | 7 (4.8) | 9 (5.9) | 0.898 | NA | NA | NA |
| Thrombus aspiration | 36 (72.0) | 126 (86.3) | 121 (79.6) | 0.063 | NA | NA | NA |
Values expressed as n (%), mean±SD, or median (25th-75th percentiles).
A p -value <0.05 (A vs. B vs. C) or p -value <0.017 (two-group comparison) was considered statistically significant.
CKD, chronic kidney disease; CK-MB, creatine kinase-MB; cTnI, cardiac troponin I; DS, diameter stenosis; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitive C-reactive protein; LAD, left anterior descending artery; LCX, left circumflex artery; LDL-C, low-density lipoprotein cholesterol; MLD, minimal lumen diameter; OCT, optical coherence tomography; pro-BNP, pro-type B natriuretic peptide; RCA, right coronary artery; RLD, reference lumen diameter; TC, total cholesterol; TG, triglyceride; TIMI, thrombolysis in myocardial infarction.
Clinical and coronary angiographical features of all STEMI patients with OCT-erosion
| Variables |
Overall (
|
|---|---|
| Clinical characteristics | |
| Age, years | 54.5±11.0 |
| Male | 276 (79.3) |
| Smoking status | |
| Never | 101 (29.0) |
| Former | 27 (7.8) |
| Current | 220 (63.2) |
| Diabetes mellitus | 52 (14.9) |
| Hypertension | 124 (35.6) |
| Dyslipidemia | 166 (47.7) |
| CKD | 20 (5.7) |
| Laboratory test | |
| TC, mg/dL | 178.0±42.7 |
| TG, mg/dL | 136.8±78.1 |
| LDL-C, mg/dL | 112.9±39.7 |
| HDL-C, mg/dL | 50.3±11.3 |
| cTnI, µg/L | 1.6 (0.3, 10.2) |
| CK-MB, U/L | 14.7 (2.0, 87.1) |
| hs-CRP, mg/L | 6.5±5.0 |
| pro-BNP, pg/ml | 302.0 (69.0, 1257.5) |
| STEMI onset to OCT imaging time, min | 300.0 (200.0, 501.5) |
| Coronary angiographic findings | |
| Culprit vessel | |
| LAD | 217 (62.4) |
| LCX | 28 (8.0) |
| RCA | 103 (29.6) |
| Segment | |
| Proximal | 159 (45.7) |
| Mid | 132 (37.9) |
| Distal | 57 (16.4) |
| Lesion length, mm | 18.2±9.0 |
| RLD, mm | 3.1±0.5 |
| MLD, mm | 1.1±0.5 |
| DS, % | 63.3±14.2 |
| Initial TIMI flow 0-1 | 226 (64.9) |
| Multivessel disease | 116 (33.3) |
| Thrombolysis | 19 (5.5) |
| Thrombus aspiration | 283 (81.3) |
Values expressed as n (%), mean±SD, or median (25th-75th percentiles).
A p -value <0.05 (A vs. B vs. C) or p -value <0.017 (two-group comparison) was considered statistically significant.
CKD, chronic kidney disease; CK-MB, creatine kinase-MB; cTnI, cardiac troponin I; DS, diameter stenosis; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high- sensitive C-reactive protein; LAD, left anterior descending artery; LCX, left circumflex artery; LDL-C, low-density lipoprotein cholesterol; MLD, minimal lumen diameter; OCT, optical coherence tomography; pro-BNP, pro-type B natriuretic peptide; RCA, right coronary artery; RLD, reference lumen diameter; TC, total cholesterol; TG, triglyceride; TIMI, thrombolysis in myocardial infarction.
Morphological characteristics of plaque erosions with different area stenosis detected by OCT
| Variables | Area stenosis |
| |||||
|---|---|---|---|---|---|---|---|
|
Group A
<50% (
|
Group B
50-75% (
|
Group C
≥ 75% (
|
A vs. B vs. C | A vs. B | B vs. C | A vs. C | |
| Area stenosis, % | 33.3±14.4 | 64.3±7.0 | 81.4±4.1 | <0.001 | <0.001 | <0.001 | <0.001 |
| MLA, mm 2 | 5.7±3.1 | 2.5±1.1 | 1.5±0.4 | <0.001 | <0.001 | <0.001 | <0.001 |
| RLA, mm 2 | 8.4±3.7 | 7.2±2.8 | 8.1±2.5 | 0.008 | 0.031 | 0.031 | 1.000 |
| Fibrous plaque | 41 (82.0) | 80 (54.8) | 53 (34.9) | <0.001 | 0.001 | 0.001 | <0.001 |
| Lipid plaque | 9 (18.0) | 66 (45.2) | 99 (65.1) | <0.001 | 0.001 | 0.001 | <0.001 |
| Lipid length, mm | 10.5±7.3 | 10.2±5.3 | 10.6±5.2 | 0.884 | NA | NA | NA |
| Mean lipid arc, ° | 207.0±40.3 | 209.7±45.5 | 228.5±50.0 | 0.033 | 1.000 | 0.041 | 0.595 |
| Maximal lipid arc, ° | 295.3±75.4 | 288.5±61.7 | 310.7±62.8 | 0.084 | NA | NA | NA |
| Minimal FCT, µm | 87.6±28.8 | 94.6±36.1 | 91.0±42.9 | 0.793 | NA | NA | NA |
| LRP | 8 (16.0) | 64 (43.8) | 95 (62.5) | <0.001 | <0.001 | 0.001 | <0.001 |
| TCFA | 2 (4.0) | 13 (8.9) | 32 (21.1) | 0.001 | 0.260 | 0.003 | 0.005 |
| Macrophage | 8 (16.0) | 82 (56.2) | 100 (65.8) | <0.001 | <0.001 | 0.088 | <0.001 |
| Microvessels | 8 (16.0) | 48 (32.9) | 60 (39.5) | 0.009 | 0.023 | 0.236 | 0.002 |
| Cholesterol crystals | 3 (6.0) | 23 (15.8) | 45 (29.6) | <0.001 | 0.079 | 0.004 | 0.001 |
| Calcification | 8 (16.0) | 42 (28.8) | 55 (36.2) | 0.023 | 0.074 | 0.172 | 0.008 |
| Spotty calcification | 3 (6.0) | 32 (21.9) | 42 (27.6) | 0.006 | 0.011 | 0.254 | 0.001 |
| Nearby bifurcation | 36 (72.0) | 98 (67.1) | 84 (55.3) | 0.036 | 0.522 | 0.036 | 0.037 |
| Distance from bifurcation to MLA, mm | 2.5±1.7 | 2.3±1.5 | 2.4±1.4 | 0.710 | NA | NA | NA |
| Layered plaque | 11 (22.0) | 65 (44.5) | 79 (52.0) | 0.001 | 0.005 | 0.198 | <0.001 |
| Layer thickness, µm | 655.0 (505.0, 787.5) | 575.0 (465.0, 775.0) | 570.0 (435.0, 775.0) | 0.760 | NA | NA | NA |
| Layer area, mm 2 | 1.4 (1.0, 2.4) | 1.2 (0.8, 2.1) | 1.4 (0.9, 2.1) | 0.573 | NA | NA | NA |
Values expressed as n (%), mean±SD, or median (25th-75th percentiles).
A p -value <0.05 (A vs. B vs. C) or p -value <0.017 (two-group comparison) was considered statistically significant.
FCT, fibrous cap thickness; LRP, lipid-rich plaque; MLA, minimal lumen area; OCT, optical coherence tomography; RLA, reference lumen area; TCFA, thin cap fibroatheroma.
OCT findings of all OCT-erosions
| Variables |
Overall (
|
|---|---|
| Area stenosis, % | 67.4±17.4 |
| MLA, mm 2 | 2.5±2.0 |
| RLA, mm 2 | 7.8±2.9 |
| Fibrous plaque | 174 (50.0) |
| Lipid plaque | 174 (50.0) |
| Lipid length, mm | 10.5±5.2 |
| Mean lipid arc, ° | 220.2±48.6 |
| Maximal lipid arc, ° | 301.4±63.6 |
| Minimal FCT, µm | 92.2±39.6 |
| LRP | 167 (48.0) |
| TCFA | 47 (13.5) |
| Macrophage | 190 (54.6) |
| Microvessels | 116 (33.3) |
| Cholesterol crystals | 71 (20.4) |
| Calcification | 105 (30.2) |
| Spotty calcification | 77 (22.1) |
| Nearby bifurcation | 218 (62.6) |
| Distance to bifurcation, mm | 2.4±1.5 |
| Layered plaque | 155 (44.5) |
| Layer thickness, µm | 570.0 (440.0, 770.0) |
| Layer area, mm 2 | 1.4 (0.9, 2.1) |
Values expressed as n (%), mean±SD, or median (25th-75th percentiles).
A p -value <0.05(A vs. B vs. C) or p -value <0.017 (two-group comparison) was considered statistically significant.
FCT, fibrous cap thickness; LRP, lipid-rich plaque; MLA, minimal lumen area; OCT, optical coherence tomography; RLA, reference lumen area; TCFA, thin cap fibroatheroma.
Univariable logistic regression analysis for OCT-erosion with noncritical stenosis
| Variables | Univariable analysis | |
|---|---|---|
|
| OR (95%CI) | |
| Age a. | 0.006 | 0.972 (0.953-0.992) |
| Male | 0.679 | 1.116 (0.663-1.880) |
| Current smoking | 0.113 | 1.427 (0.920-2.213) |
| Diabetes mellitus | 0.320 | 0.741 (0.411-1.338) |
| Hypertension | 0.027 | 0.607 (0.390-0.944) |
| Dyslipidemia | 0.105 | 1.423 (0.929-2.179) |
| CKD | 0.902 | 0.945 (0.381-2.341) |
| TC b. | 0.348 | 1.002 (0.997-1.008) |
| TG b. | 0.292 | 1.002 (0.999-1.004) |
| LDL-C b. | 0.185 | 1.004 (0.998-1.010) |
| HDL-C b. | 0.985 | 1.000 (0.981-1.019) |
| LAD | 0.005 | 1.889 (1.217-2.932) |
| Multivessel disease | 0.033 | 0.613 (0.391-0.961) |
| Initial TIMI flow 0-1 | 0.698 | 1.092 (0.701-1.701) |
| Thrombolysis | 0.739 | 0.854 (0.338-2.158) |
| Thrombus aspiration | 0.470 | 1.221 (0.711-2.096) |
| Lesion length c. | 0.364 | 0.984 (0.951-1.018) |
| RLA d. | 0.083 | 0.936 (0.869-1.009) |
| Fibrous plaque | <0.001 | 3.014 (1.939-4.683) |
| Macrophage | <0.001 | 0.442 (0.285-0.684) |
| Microvessels | 0.033 | 0.613 (0.391-0.961) |
| Cholesterol crystals | <0.001 | 0.364 (0.212-0.624) |
| Calcification | 0.032 | 0.604 (0.381-0.958) |
| Nearby bifurcation | 0.013 | 1.750 (1.128-2.714) |
| Layered plaque | 0.014 | 0.585 (0.381-0.899) |
a. OR for age was calculated for each 1-year increase; b. OR for TC, TG, LDL-C and HDL-C were calculated for each 1.0 mg/dL increase; c. OR for lesion length was calculated for each 1mm increase; d. OR for RLA was calculated for each 1 mm 2 increase.
CI, confidence interval; CKD, chronic kidney disease; HDL-C, high-density lipoprotein cholesterol; LAD, left anterior descending artery; LDL-C, low-density lipoprotein cholesterol; LRP, lipid-rich plaque; OCT, optical coherence tomography; OR, odds ratio; RLA, reference lumen area; TC, total cholesterol; TG, triglyceride; TIMI, thrombolysis in myocardial infarction.